http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0491911-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0571327c8407d415e41966dd96499e42 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 1991-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb80e6c8165734f8c636fb361c4a2554 |
| publicationDate | 1992-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0491911-A1 |
| titleOfInvention | A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs |
| abstract | Pharmaceutical composition for the controlled release of non-steroidal anti-inflammatory drugs and the achievement of effective plasma drug levels for twelve to twenty-four hours. Said controlled release composition comprises: a) 3 or 4 unit doses (nuclei) each containing one third or one quarter of the total dose of the drug respectively, said unit doses being made up of tablets which can disintegrate and / or tablets which cannot disintegrate, comprising the active ingredient as well as hydrophilic polymeric substances capable of gradually releasing the active ingredient; and b) hard capsules containing three or four unit doses to be released. |
| priorityDate | 1990-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.